Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-01-25 @ 6:11 AM
Study NCT ID:
NCT05797805
Status:
RECRUITING
Last Update Posted:
2025-07-04
First Post:
2023-03-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
Sponsor:
Iterion Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-13
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-08
First Submit QC Date:
None
Study First Post Date:
2023-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-01
Last Update Post Date:
2025-07-04
Last Update Post Date Type:
ACTUAL